ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION
Clinical trials for ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION trials appear
Sign up with your email to follow new studies for ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Shot hope: drug may shield fertility in women facing stem cell transplant
Disease control Not yet recruitingThis study tests whether a single injection of goserelin, given just before a stem cell transplant, can help preserve ovarian function in women with blood cancers. The trial will enroll 64 women aged 14-50 and measure menstrual recovery six months after transplant. If successful,…
Matched conditions: ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: NA • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Single shot may shield fertility in women facing stem cell transplant
Disease control Not yet recruitingThis study tests whether a single injection of goserelin, given just before a stem cell transplant, can help preserve ovarian function in women with severe aplastic anemia. The trial will enroll 132 women aged 14–50 and compare menstrual recovery rates six months after transplant…
Matched conditions: ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: NA • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC